Conway, Richard <br/><br/>
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial.  [electronic resource] 

 -  Seminars in arthritis and rheumatism  12 2018 
 - 523-528 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-866X 
<br/><br/><label>Standard No.: </label>10.1016/j.semarthrit.2018.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Giant Cell Arteritis--drug therapy<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Prednisolone--therapeutic use<br/>Treatment Outcome<br/>Ustekinumab--therapeutic use